Morningstar - CapitaLand Limited (C31) CCT Ventures Into Europe With Acquisition of Gallileo in Germany; FVE Raised to SGD 1.70

Report

Morningstar

Michael Wu

CCT Ventures Into Europe With Acquisition of Gallileo in Germany; FVE Raised to SGD 1.70

CapitaLand Commercial Trust, or CCT, has announced that it will acquire a 94.9% stake in Gallileo, a Grade A freehold commercial property in Frankfurt, Germany, for EUR 342.7 million, or approximately SGD 548.3 million. Meanwhile, the remainder 5.1% stake will be acquired by CCTâ€™s parent company, CapitaLand Limited. The property is fully occupied, and on a 100% basis, the agreed property value of EUR 356 million (or SGD 569.6 million), represents a 1.4% discount to the independent valuation of t...

17/05/2018 13 EN

Underlying

CapitaLand Limited

CapitaLand is a real estate company based in Singapore. Co. is engaged in real estate development, investment in real estate, financial products and real estate assets, investment advisory and management services as well as management of serviced residences. Co.'s real estate portfolio includes integrated developments, shopping malls, serviced residences, offices and homes. Co.'s two core markets are Singapore and China. Co. maintains a real estate fund management businesses with assets located in Asia. Co.'s listed real estate investment trusts are: Ascott Residence Trust, CapitaLand Commercial Trust, CapitaLand Mall Trust, CapitaLand Retail China Trust and CapitaMalls Malaysia Trust.

See profile

SG1J27887962 Singapore Exchange Singapore

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Michael Wu

Other Reports on these Companies

MarketLine

Henderson Land Development Co Ltd - Company Profile and SWOT Analysis

Summary Henderson Land Development Co Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Henderson Land Development Co Ltd (Henderson) is a real estate, and property developer. It carries out property development, and property investment. Its portfolio of properties includes industrial buildings, residential properties, hotel and serviced apartments, office buildings, sh...

EUR 150.50

June 28, 2024 June 28, 2024 1 EN

Aequitas Research

CICT Placement

CapitaLand Integrated Commercial Trust (CICT) aims to raise around US$150m to partly fund the recently announced acquisition of two Australian assets. Although, at the time of the acquisition the company had stated that it aims to finance the acquisition using debt and divestment proceeds. In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

EUR 86.00

December 7, 2021 December 7, 2021 7 EN

UOB

Strategy - Imminent changes to MSCI Singapore weightings

From 1 Sep 21, Sea Limited’s weighting within the MSCI Singapore index will increase from 2.5% to 11.0% which we believe will see more ETF-related buying of the stock. The unfortunate ramification is that funds will sell out of the largest constituents which include DBS, OCBC, UOB, and Singtel. We also highlight that Yangzijiang’s share price strength (+68% ytd) may potentially see its re-inclusion in the near to medium term.

August 30, 2021 August 30, 2021 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

CCT Ventures Into Europe With Acquisition of Gallileo in Germany; FVE Raised to SGD 1.70

Henderson Land Development Co Ltd - Company Profile and SWOT Analysis

CICT Placement

Strategy - Imminent changes to MSCI Singapore weightings

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe